Discontinued — last reported Q4 '20
Year-over-year, this metric declined by 100.0%, from $1.50M to $0.00.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $169.71M | $5.23M | $1.40M | $0.00 | $9.46M | $809.60M | $300.00K | $1.50M | $3.16M | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | — | — | -96.9% | -73.3% | -100.0% | — | >999% | -100.0% | +400.0% | +110.5% | -100.0% | — | — |
| YoY Change | — | — | — | — | — | — | -100.0% | — | — | -96.8% | — | — | -100.0% | -100.0% | -100.0% |